A detailed history of Jamison Private Wealth Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 54,181 shares of ABBV stock, worth $10.5 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
54,181
Previous 52,226 3.74%
Holding current value
$10.5 Million
Previous $9.51 Billion 2.28%
% of portfolio
1.54%
Previous 1.61%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $302,614 - $353,385
1,955 Added 3.74%
54,181 $9.29 Billion
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $125,298 - $142,766
784 Added 1.52%
52,226 $9.51 Billion
Q4 2023

Jan 17, 2024

SELL
$137.6 - $154.97 $14,310 - $16,116
-104 Reduced 0.2%
51,442 $7.97 Billion
Q3 2023

Jan 05, 2024

BUY
$133.59 - $154.65 $6.89 Million - $7.97 Million
51,546 New
51,546 $7.68 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jamison Private Wealth Management, Inc. Portfolio

Follow Jamison Private Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jamison Private Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jamison Private Wealth Management, Inc. with notifications on news.